0001729659-18-000002.txt : 20180206 0001729659-18-000002.hdr.sgml : 20180206 20180206162518 ACCESSION NUMBER: 0001729659-18-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20180206 DATE AS OF CHANGE: 20180206 EFFECTIVENESS DATE: 20180206 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Daisy Pharma Opioid Venture, LLC CENTRAL INDEX KEY: 0001729659 IRS NUMBER: 822887370 STATE OF INCORPORATION: AZ FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-304949 FILM NUMBER: 18577896 BUSINESS ADDRESS: STREET 1: PO BOX 27170 CITY: SCOTTSDALE STATE: AZ ZIP: 85255 BUSINESS PHONE: 480-355-9000 MAIL ADDRESS: STREET 1: PO BOX 27170 CITY: SCOTTSDALE STATE: AZ ZIP: 85255 D 1 primary_doc.xml X0708 D LIVE 0001729659 Daisy Pharma Opioid Venture, LLC 23623 N. Scottsdale Rd., #D3269 SCOTTSDALE AZ ARIZONA 85255 480-355-9000 ARIZONA None None Limited Liability Company true 2017 Brent Berj Nerguizian 23623 N. Scottsdale Rd. #D3269 Scottsdale AZ ARIZONA 85255 Executive Officer Kendric Burton Speagle 23623 N. Scottsdale Rd., #D3269 Scottsdale AZ ARIZONA 85255 Executive Officer Pharmaceuticals No Revenues 06c false true false true false 1000000 75000000 0 75000000 false 0 4000000 true 0 10000000 Purchase of drug discovery intellectual property, patents from related persons, management fees for drug development paid forward to officer related parties. false Daisy Pharma Opioid Venture, LLC Brent Nerguizian Brent Nerguizian CEO 2018-02-06